71 related articles for article (PubMed ID: 336881)
1. Scanning and transmission electron microscopy of leptomeningeal free cells: cell interactions in response to challenge by bacillus Calmette-Guerin.
Merchant RE; Olson GE; Low FN
J Reticuloendothel Soc; 1977 Sep; 22(3):199-207. PubMed ID: 336881
[No Abstract] [Full Text] [Related]
2. Identification of challenged subarachnoid free cells.
Merchant RE; Low FN
Am J Anat; 1977 Jan; 148(1):143-8. PubMed ID: 320859
[TBL] [Abstract][Full Text] [Related]
3. Scanning electron microscopy of the subarachnoid space in the dog. V. Macrophages challenged by bacillus Calmette-Guerin.
Merchant RE; Low FN
J Comp Neurol; 1977 Apr; 172(3):381-407. PubMed ID: 320233
[TBL] [Abstract][Full Text] [Related]
4. Morphological evidence for the translocation of lysosomal organelles from cytotoxic macrophages into the cytoplasm of tumor target cells.
Bucana C; Hoyer LC; Hobbs B; Breesman S; McDaniel M; Hanna MG
Cancer Res; 1976 Dec; 36(12):4444-58. PubMed ID: 187323
[TBL] [Abstract][Full Text] [Related]
5. Human phagocytic cell responses to Mycobacterium leprae and Mycobacterium bovis Bacillus Calmette-Guérin. An in vitro comparison of leprosy vaccine components.
Holzer TJ; Kizlaitis L; Vachula M; Weaver CW; Andersen BR
J Immunol; 1988 Sep; 141(5):1701-8. PubMed ID: 3137262
[TBL] [Abstract][Full Text] [Related]
6. Scanning electron microscopy of the subarachnoid space in the dog: evidence for a non-hematogenous origin of subarachnoid macrophages.
Merchant RE; Low FN
Am J Anat; 1979 Oct; 156(2):183-206. PubMed ID: 389020
[TBL] [Abstract][Full Text] [Related]
7. Immunohistochemical markers augment evaluation of vaccine efficacy and disease severity in bacillus Calmette-Guerin (BCG) vaccinated cattle challenged with Mycobacterium bovis.
Johnson L; Gough J; Spencer Y; Hewinson G; Vordermeier M; Wangoo A
Vet Immunol Immunopathol; 2006 Jun; 111(3-4):219-29. PubMed ID: 16540176
[TBL] [Abstract][Full Text] [Related]
8. Influence of immunisation with Mycobacterium bovis bacillus Calmette-Guérin on the sensitisation to inhaled allergens after infection with respiratory syncytial virus.
Vonberg RP; Mueller M; Emmendoerffer A; Freihorst J
Clin Exp Med; 2005 Dec; 5(4):177-83. PubMed ID: 16362797
[TBL] [Abstract][Full Text] [Related]
9. The effect of Mycobacterium bovis (Bacillus Calmette-Guérin) on macrophage random migration, chemotaxis, and pinocytosis.
Poplack DG; Sher NA; Chaparas SD; Blaese RM
Cancer Res; 1976 Apr; 36(4):1233-7. PubMed ID: 769964
[TBL] [Abstract][Full Text] [Related]
10. Effect of Myobacterium bovis (strain Bacillus Calmette-Guérin) on macrophage production by the bone marrow of tumor-bearing mice.
Fisher B; Taylor S; Levine M; Saffer E; Fisher ER
Cancer Res; 1974 Jul; 34(7):1668-70. PubMed ID: 4599359
[No Abstract] [Full Text] [Related]
11. CD4+ T-cell activation by antigen-presenting cells infected with urease-deficient recombinant Mycobacterium bovis bacillus Calmette-Guérin.
Mukai T; Maeda Y; Tamura T; Miyamoto Y; Makino M
FEMS Immunol Med Microbiol; 2008 Jun; 53(1):96-106. PubMed ID: 18400013
[TBL] [Abstract][Full Text] [Related]
12. Bacillus Calmette-Guerin induced macrophage stimulation: humoral aspects.
Megirian R; Saba TM; Stephenson JB
J Reticuloendothel Soc; 1976 Nov; 20(5):341-8. PubMed ID: 794469
[No Abstract] [Full Text] [Related]
13. Scanning electron microscopy of epiplexus macrophages responding to challenge by bacillus Calmette-Guerin.
Merchant RE
Acta Neuropathol; 1979 Aug; 47(3):183-8. PubMed ID: 384740
[TBL] [Abstract][Full Text] [Related]
14. Infection with Bacillus Calmette-Guérin activates murine thymus-independent (B) lymphocytes.
Sultzer BM
J Immunol; 1978 Jan; 120(1):254-61. PubMed ID: 342604
[TBL] [Abstract][Full Text] [Related]
15. Mycobacterium bovis Bacillus Calmette-Guerin infects DC-SIGN- dendritic cell and causes the inhibition of IL-12 and the enhancement of IL-10 production.
Gagliardi MC; Teloni R; Giannoni F; Pardini M; Sargentini V; Brunori L; Fattorini L; Nisini R
J Leukoc Biol; 2005 Jul; 78(1):106-13. PubMed ID: 15845642
[TBL] [Abstract][Full Text] [Related]
16. New insights into the effects of Mycobacterium bovis Bacillus Calmette-Guérin on asthma.
Zhang GS; Wang PL; Huang HQ; Shen HH
Chin Med J (Engl); 2009 Mar; 122(5):577-83. PubMed ID: 19323911
[No Abstract] [Full Text] [Related]
17. Bacillus Calmette-Guerin, Mycobacterium bovis, as an immunomodulator in atopic diseases.
Barlan I; Bahceciler NN; Akdis M; Akdis CA
Immunol Allergy Clin North Am; 2006 May; 26(2):365-77, ix. PubMed ID: 16701150
[TBL] [Abstract][Full Text] [Related]
18. Studies on the immunogical effects of BCG and its components: theoritical and therapeutic implications.
Mitchell MS
Biomedicine; 1976; 24(4):209-13. PubMed ID: 791387
[TBL] [Abstract][Full Text] [Related]
19. Human T cell responses induced by vaccination with Mycobacterium bovis bacillus Calmette-Guérin.
Ravn P; Boesen H; Pedersen BK; Andersen P
J Immunol; 1997 Feb; 158(4):1949-55. PubMed ID: 9029137
[TBL] [Abstract][Full Text] [Related]
20. Newborns develop a Th1-type immune response to Mycobacterium bovis bacillus Calmette-Guérin vaccination.
Marchant A; Goetghebuer T; Ota MO; Wolfe I; Ceesay SJ; De Groote D; Corrah T; Bennett S; Wheeler J; Huygen K; Aaby P; McAdam KP; Newport MJ
J Immunol; 1999 Aug; 163(4):2249-55. PubMed ID: 10438968
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]